Form 4: Tivic Health CFO Acquires Shares via RSU Vesting
Insider Transaction Report
Tivic Health Systems' Chief Financial Officer, Lisa G. Wolf, acquired 92 shares of common stock through the vesting of Restricted Stock Units.
Summary
- Lisa G. Wolf, Chief Financial Officer of Tivic Health Systems, Inc. (TIVC), acquired 92 shares of common stock.
- The transaction occurred on March 18, 2026, through the conversion of Restricted Stock Units (RSUs).
- Following this acquisition, Wolf directly owns 526 shares of common stock.
- An additional 643 Restricted Stock Units remain beneficially owned by Wolf.
- All reported numbers have been adjusted to reflect a 1-for-17 reverse stock split of Tivic Health Systems, Inc. common stock, which became effective on March 7, 2025.
- Fifty percent of the original Restricted Stock Units vested on December 18, 2024, and the remaining balance will vest in eight successive equal quarterly installments, with full vesting by December 18, 2027.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive signal, as it represents an insider increasing their direct ownership, albeit through a pre-scheduled vesting event rather than an open market purchase, which still aligns executive interests with shareholders.
Positives
- Insider acquisition of shares, even through vesting, can signal continued confidence in the company's long-term prospects.
- The multi-year vesting schedule for the remaining RSUs provides a long-term incentive for the Chief Financial Officer, aligning her interests with shareholder value creation.
Future Outlook
The remaining 643 Restricted Stock Units held by the CFO are scheduled to vest in eight successive equal quarterly installments, with full vesting expected by December 18, 2027, indicating a structured long-term incentive for executive retention and performance.
Industry Context
StockSavvy.ai notes that insider transactions, particularly those involving equity compensation vesting, are common and reflect standard executive compensation practices. While not a direct market signal of new strategic initiatives, the continued accumulation of shares by a key executive like the CFO aligns their interests with long-term shareholder value. The prior reverse stock split is a corporate action often undertaken by companies to meet listing requirements or improve stock perception, a common occurrence in the micro-cap segment of the healthcare technology industry.
Comparison to Industry Standards
- StockSavvy.ai observes that equity compensation, including Restricted Stock Units with multi-year vesting schedules, is a standard practice across various industries, particularly in technology and healthcare sectors where long-term retention and alignment of executive interests are crucial. Companies like Medtronic (MDT) and Intuitive Surgical (ISRG) frequently utilize similar RSU programs for their executives to incentivize sustained performance and commitment.
- The 1-for-17 reverse stock split, while not directly comparable to RSU programs, is a corporate action often seen in micro-cap companies aiming to meet listing requirements or improve stock perception, a strategy also employed by companies like Sorrento Therapeutics (SRNEQ) in the past.
Related Party Transactions
- Acquisition of common stock by the Chief Financial Officer through the vesting of Restricted Stock Units, which is a standard form of equity compensation from the company.
Stakeholder Impact
- Shareholders: The transaction increases the Chief Financial Officer's direct equity ownership, further aligning her financial interests with the long-term performance and value creation for shareholders.
- Employees: This reflects standard executive compensation practices, which can serve as a benchmark for other employees' equity incentive programs.
Next Steps
- The remaining 643 Restricted Stock Units are scheduled to vest in eight successive equal quarterly installments.
- Full vesting of the Restricted Stock Units is expected by December 18, 2027.
Key Dates
| Date | Description |
|---|---|
| 03/07/2025 | Effective date of the 1-for-17 reverse stock split for Tivic Health Systems, Inc. common stock. |
| 12/18/2024 | Vesting Commencement Date for Restricted Stock Units, with 50% of the units vesting. |
| 03/18/2026 | Transaction Date for the acquisition of common stock resulting from RSU conversion. |
| 03/19/2026 | Signature Date of the reporting person on the Form 4 filing. |
| 12/18/2027 | Expected date for 100% vesting of the Restricted Stock Units. |
Recommendation
holdThis Form 4 reports a routine insider transaction involving the vesting of Restricted Stock Units and subsequent acquisition of common stock by the CFO. While it indicates continued insider ownership and alignment, it does not provide new fundamental information about the company's operational performance or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more substantive financial or operational updates.
Keywords
Tivic Health Systems, TIVC, Insider Transaction, Form 4, Restricted Stock Units, RSU, Common Stock, Lisa G. Wolf, CFO, Equity Compensation, Reverse Stock Split
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.